2019
DOI: 10.1080/10799893.2019.1660893
|View full text |Cite
|
Sign up to set email alerts
|

Cardiotonic steroids as potential Na+/K+-ATPase inhibitors – a computational study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 41 publications
0
13
0
Order By: Relevance
“…Cardenolides have been used for the treatment of congestive heart failure and atrial arrhythmias (Scalese and Salvatore 2017; Whayne 2018). They act as inhibitors of the Na + /K + -ATPase by suppressing the sodium pump (Patel et al 2019). In our study, preliminary data suggest that DIGI targets the L. infantum mitochondria, causing alterations in both the parasite mitochondrial membrane potential and integrity, as well as an increase in ROS production.…”
Section: Discussionmentioning
confidence: 56%
See 1 more Smart Citation
“…Cardenolides have been used for the treatment of congestive heart failure and atrial arrhythmias (Scalese and Salvatore 2017; Whayne 2018). They act as inhibitors of the Na + /K + -ATPase by suppressing the sodium pump (Patel et al 2019). In our study, preliminary data suggest that DIGI targets the L. infantum mitochondria, causing alterations in both the parasite mitochondrial membrane potential and integrity, as well as an increase in ROS production.…”
Section: Discussionmentioning
confidence: 56%
“…Thus, drug repositioning may well represent an attractive alternative, since compounds with known biological functions have been proved to be effective against parasites (Andrade-Neto et al 2018). Cardenolides are glycosides able to inhibit Na + /K + -ATPases by obstructing the Na + /K + pump mechanism (Mijatovic and Kiss 2013;Patel et al 2019). These compounds are clinically used to treat cardiac diseases, such as congestive heart failure (Gheorghiade et al 2009), and they have been reported also to possess antitumor (Slingerland et al 2013), antimalarial (Chan et al 2016), and antioxidant (Xu et al 2017) activities, among others (Eid et al 2012;Gurel et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Molecular dynamics simulations were carried out in Desmond (Schrödinger Release 2019-3) package [ 48 ] with the best-scoring, top-five NPACT compounds of HE target as starting structures. We also performed simulations on the HE crystal structure in complex with 4,9- O ′-diacetyl sialic acid (cognate ligand) to utilize it as control.…”
Section: Methodsmentioning
confidence: 99%
“…Virtual screening was performed on CoV-2 HE target receptor with 1574 NPACT compounds as ligand set using YASARA Structure package (version 19.12.14; academic license). YASARA Structure implements AutoDock Vina as the dock pose search algorithm and AMBER03 force field for scoring receptor-ligand interactions [48]. Initially, the docking procedure was validated by re-docking the co-crystal ligand of HE target 4,9-O′-diacetyl sialic acid with the 20 × 20 × 20 Å grid box size (dock site) The re-docked ligand was evaluated using root mean square deviation (RMSD) measure.…”
Section: Virtual Screening Upon He Targetmentioning
confidence: 99%
“…Molecular docking was implemented on coronavirus hemagglutinin-esterase and 1574 NPACT compounds using YASARA software version 19.12.14 with AutoDock Vina algorithm and AMBER03 force field [40][41][42]. The docking scores were calculated using the following empirical equation:…”
Section: Molecular Dockingmentioning
confidence: 99%